8-K
Current Report
Spyre Therapeutics, Inc. Filed Acc 0001636282-25-000063
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading syre-20250529.htm…